Intellectual property lawfromIntellectual Property Law Blog2 days agoBiopharmaceutical Patent Litigation: Regeneron's Defense Against Biosimilar LaunchesRegeneron is actively defending its EYLEA patents against biosimilar manufacturers in court.
Intellectual property lawfromPatently-O2 months agoDesign-Around Victory: Amgen's Self-Buffering Innovation Regeneron's ClaimsThe Federal Circuit affirmed Amgen's biosimilar, emphasizing its unique formulation and contrasting it with prior rulings against other manufacturers.